|
⚲
|
| Keyboard |
| CytomX Therapeutics Inc | |
|---|---|
| Ticker | CTMX |
| CIK # | 0001501989 |
| CUSIP | 23284F105 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 343 Oyster Point Blvd Suite 100, South San Francisco, CA 94080 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| CytomX Therapeutics Inc | 2023-08-17 | 30.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001501989] | 10-K | |
| [0001501989] | 10-Q | |
| [0001501989] | 3 | |
| [0001501989] | 4 | |
| [0001501989] | 5 | |
| [0001501989] | 8-K | |
| [0001501989] | D | |
| [0001501989] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Belvin Marcia
Common Stock
|
2026-03-17 | Sell | 31,492 | $6.42 | 202,179 |
|
Ogden Christopher
Common Stock
|
2026-03-17 | Sell | 19,323 | $6.42 | 124,054 |
|
Chu Yu-Waye
Common Stock
|
2026-03-17 | Sell | 21,279 | $6.42 | 136,611 |
|
McCarthy Sean A
Common Stock
|
2026-03-17 | Sell | 118,969 | $6.42 | 763,781 |
|
Lester Rachael
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 50,000 | $0.00 | |
|
Belvin Marcia
Common Stock
|
2026-02-02 | Grant | 60,000 | $0.00 | |
|
Lester Rachael
Common Stock
|
2026-02-02 | Grant | 20,000 | $0.00 | |
|
Chu Yu-Waye
Common Stock
|
2026-02-02 | Grant | 75,000 | $0.00 | |
|
McCarthy Sean A
Common Stock
|
2026-02-02 | Grant | 210,000 | $0.00 | |
|
Chu Yu-Waye
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 300,000 | $0.00 | |
|
Ogden Christopher
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 325,000 | $0.00 | |
|
Ogden Christopher
Common Stock
|
2026-02-02 | Grant | 90,000 | $0.00 | |
|
Lester Rachael
Performance Stock Units (PSUs) · derivative
|
2026-02-02 | Grant | 50,000 | $0.00 | |
|
McCarthy Sean A
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 980,000 | $0.00 | |
|
Belvin Marcia
Stock Option (Right to Buy) · derivative
|
2026-02-02 | Grant | 250,000 | $0.00 | |
|
McCarthy Sean A
Class A Common Stock
|
2025-11-06 | Sell | 101,793 | $4.54 | 462,140 |
|
Lester Rachael
Stock Option (Right to Buy) · derivative
|
2025-10-20 | Grant | 650,000 | $0.00 | |
|
Stock Option (Right to Buy) · derivative
|
2025-09-26 | Grant | 87,500 | $0.00 | |
|
Performance Stock Units (PSUs) · derivative
|
2025-09-26 | Grant | 18,150 | $0.00 | |
|
Performance Stock Units (PSUs) · derivative
|
2025-09-26 | Grant | 285,000 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 181 | 197,520,754 |
| 2025-12-31 | 122 | 144,488,286 |
| 2025-09-30 | 104 | 138,534,855 |
| 2025-06-30 | 85 | 132,418,518 |
| 2025-03-31 | 67 | 42,100,025 |
| 2024-12-31 | 71 | 43,590,511 |
| 2024-09-30 | 71 | 48,216,425 |
| 2024-06-30 | 75 | 48,007,141 |
| 2024-03-31 | 89 | 43,684,980 |
| 2023-12-31 | 69 | 30,100,783 |
| 2023-09-30 | 63 | 29,788,668 |
| 2023-06-30 | 68 | 31,516,176 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Assenagon Asset Management SA | [2026-06-30] | SOLE | 364,173 | 364,173 |
| TEMA ETFS LLC | [2026-06-30] | SOLE | 228,987 | 228,987 |
| Merit Financial Group LLC | [2026-06-30] | SOLE | 0 | 53,443 |
| Congress Park Capital LLC | [2026-06-30] | SOLE | 0 | 49,171 |
| PSP Research LLC | [2026-06-30] | SOLE | 0 | 39,400 |
| Formidable Asset Management LLC | [2026-06-30] | SOLE | 17,710 | 17,710 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 3,169 |
| Merit Financial Group LLC | [2026-06-30] | OTR | 0 | 60 | Prev | Page 1 | Next |